Pharmafile Logo

Lucid celebrate big wins at PMEA 2015

November 26, 2015 | Awards, PMEA 2015, medical education 

Success for Lucid at PMEA 2015

Lucid group successfully supported AbbVie and Genzyme to win two awards at last night’s ceremony in London.

PEER (Psoriasis Expert Exchange FoRum) won the award for Excellence in Physicians/Healthcare Provider Support Programmes. This programme focussed on changing clinical behaviour on a global scale to improve standards of care in the management of psoriatic disease.

Commenting on the award, the judges said “The work around the Psoriasis Expert Exchange FoRum [PEER] showed an excellent understanding of the market and took a patient-centred approach from the outset. This was an ambitious programme reaching 3,200 physicians in 25 countries that achieved behavioural change which resulted in improved patient outcomes. A very comprehensive, sophisticated programme with great penetration. Congratulations to the AbbVie team.”

- PMLiVE
PEER epitomises Lucid group’s dedication to changing behaviour and improving patient outcomes.

Lucid also supported AbbVie to win the highly commended award in this category for its Treat to Target UK (T2TUK) programme. This programme focussed on driving implementation of the T2TUK recommendations across the UK.
 
And they celebrated with Genzyme after supporting them to win the award for launch excellence.

Lucid group were also proud to sponsor the award for Excellence in Continuous Development: Education Services for Global or Emerging Markets, which was won by Novo Nordisk for their Changing Diabetes in Children programme.

Dennis O’Brien Lucid group CEO commented 
“we are lucky to have a group of talented clients, who truly work in partnership with us to build programmes that make a difference.  It was great to be able to support them in their work and to celebrate their success with them”

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group bolsters its senior client services team with two magical new hires

Lucid Group boosts its senior client services team with the arrival of David Pearce and Sandra Burke, both as client operational directors.With 15 years of Med Comms experience, David has...

The Power of Teamwork #LucidLife

At our summer meeting we came together to experience the real power of #teamwork through drumming, learning to listen and react as one voice #MedEd #MedComms #CompanyMeeting #AfricanDrumming #LucidLife

Lucid Group supercharges its client services team with four spellbinding new hires

Lucid Group makes four magical additions to its client services team!Annabel Lloyd joins Vivid as an account director. With experience in a variety of therapy areas from immunology, oncology, CVD...

Lucid Group ‘Moves up’ at its spellbinding annual summer meeting

Lucid Group celebrated summer in style last week with its annual summer meeting. Lucidians from across the country descended on Lucid Towers for a spellbinding meeting centred on mental wellbeing....

Bluedog is bursting with new creative and digital talent

Bluedog, a Lucid Group company, welcomes four spellbinding new additions to its team.With a strong background in animation, Rachel Sparks joins Bluedog as a motion designer. Having previously worked in...

Lucid Group win Medical Consultancy of the Year award at Communiqué 2019

Lucid Group continues to display its magic by winning the Porterhouse Medical Group Award for Medical Consultancy of the Year 2019.However, the wins did not stop there, as Vivid, a...

Lucid has been celebrating 10 years of professionalism and unwavering passion

Lucid recognises, rewards and celebrates long-term service with flowers, vouchers and additional holiday for those who have been with the company for five and ten years. With over 20% of...

Trends in the Pharma Industry – A Lucid Thirsty Thursday Session

Rob Apollo, Corporate Development Director of Lucid Group, kicked off the first of a series of Thirsty Thursday sessions with a thought-provoking discussion around trends in the pharma industry and...